Matches in SemOpenAlex for { <https://semopenalex.org/work/W2396267066> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W2396267066 endingPage "81" @default.
- W2396267066 startingPage "77" @default.
- W2396267066 abstract "Objective To evaluate the overall efficacy and transplant-related mortality (TRM) of related and unrelated allogeneic peripheral blood hematopoietic stem cell transplantation (allo-PBSCT) in chronic myeloid leukemia (CML) patients conditioned with fludarabine-busulfan (FB) reduced intensity regimen. Methods Forty-four patients received FB (Flud 30 mgxm(-2)xd(-1) x 5 d, BU 4 mgxkg(-1)xd(-1) x 3 d) conditioning followed by allo-PBSCT. Of them, 29 patients were transplanted with related donor and 15 unrelated donor (URD). All patients received mycophenolate mofetil (MMF), CsA and MTX for acute GVHD (aGVHD) prophylaxis. 5 mg/kg rabbit-antithymocyte globulin (ATG-Fresenius) was incorporated in 15 URD recipients. Results All patients were successfully engrafted. The median times to ANC above 0.5 x 10(9)/L in related (RG) and unrelated groups (URG) were 13.7 (9 - 18) d and 13.6 (12 - 17) d, and PLT above 20 x 10(9)/L were 15.3 (9 - 20) d and 14.7 (10 - 26) d, respectively. Two patients in RG. 1 in URG developed graft rejection 5 - 8 months after transplantation. One of the two patients in RG received second transplantation and engrafted. The cumulative incidence of aGVHD and cGVHD were 13.8% (4/29) and 46.4% (13/28) in RG, and were 33.3% (5/15) and 57.1% (8/14) in URG respectively. Two patients in RG relapsed after transplantation, and obtained CR again after donor stem cell infusion (DSI). Median time of follow-up was 34.7 (2 - 73) months. Thirty-four patients were alive and 10 died. The main causes of death were IP, GVHD, graft rejection and infection. The 5-year overall survival (OS) probability was 77.0%, and the disease-free-survival (DFS) was 73.9%, of which, 79.0% and 74.1% were in RG, and 73.3% and 73.3% in URG, respectively. Conclusions Fludarabine-busulfan based reduced intensity conditioning for allo-PBSCT with either related or unrelated donors is a safe, less toxic and curative approach to CML." @default.
- W2396267066 created "2016-06-24" @default.
- W2396267066 creator A5011841901 @default.
- W2396267066 creator A5014577460 @default.
- W2396267066 creator A5026389808 @default.
- W2396267066 creator A5028948842 @default.
- W2396267066 creator A5034579434 @default.
- W2396267066 creator A5036687874 @default.
- W2396267066 creator A5037989560 @default.
- W2396267066 creator A5042921774 @default.
- W2396267066 creator A5046004951 @default.
- W2396267066 creator A5056150155 @default.
- W2396267066 creator A5066243142 @default.
- W2396267066 creator A5071932271 @default.
- W2396267066 creator A5087161790 @default.
- W2396267066 date "2010-02-01" @default.
- W2396267066 modified "2023-09-26" @default.
- W2396267066 title "Reduced intensity conditioning regimen for related and unrelated allogeneic peripheral blood hematopoietic stem cell transplantation in chronic myeloid leukemia." @default.
- W2396267066 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20302792" @default.
- W2396267066 hasPublicationYear "2010" @default.
- W2396267066 type Work @default.
- W2396267066 sameAs 2396267066 @default.
- W2396267066 citedByCount "0" @default.
- W2396267066 crossrefType "journal-article" @default.
- W2396267066 hasAuthorship W2396267066A5011841901 @default.
- W2396267066 hasAuthorship W2396267066A5014577460 @default.
- W2396267066 hasAuthorship W2396267066A5026389808 @default.
- W2396267066 hasAuthorship W2396267066A5028948842 @default.
- W2396267066 hasAuthorship W2396267066A5034579434 @default.
- W2396267066 hasAuthorship W2396267066A5036687874 @default.
- W2396267066 hasAuthorship W2396267066A5037989560 @default.
- W2396267066 hasAuthorship W2396267066A5042921774 @default.
- W2396267066 hasAuthorship W2396267066A5046004951 @default.
- W2396267066 hasAuthorship W2396267066A5056150155 @default.
- W2396267066 hasAuthorship W2396267066A5066243142 @default.
- W2396267066 hasAuthorship W2396267066A5071932271 @default.
- W2396267066 hasAuthorship W2396267066A5087161790 @default.
- W2396267066 hasConcept C126322002 @default.
- W2396267066 hasConcept C141071460 @default.
- W2396267066 hasConcept C2776694085 @default.
- W2396267066 hasConcept C2776755627 @default.
- W2396267066 hasConcept C2777408962 @default.
- W2396267066 hasConcept C2778729363 @default.
- W2396267066 hasConcept C2779263901 @default.
- W2396267066 hasConcept C2780611847 @default.
- W2396267066 hasConcept C2781413609 @default.
- W2396267066 hasConcept C2911091166 @default.
- W2396267066 hasConcept C71924100 @default.
- W2396267066 hasConcept C88879693 @default.
- W2396267066 hasConcept C90924648 @default.
- W2396267066 hasConceptScore W2396267066C126322002 @default.
- W2396267066 hasConceptScore W2396267066C141071460 @default.
- W2396267066 hasConceptScore W2396267066C2776694085 @default.
- W2396267066 hasConceptScore W2396267066C2776755627 @default.
- W2396267066 hasConceptScore W2396267066C2777408962 @default.
- W2396267066 hasConceptScore W2396267066C2778729363 @default.
- W2396267066 hasConceptScore W2396267066C2779263901 @default.
- W2396267066 hasConceptScore W2396267066C2780611847 @default.
- W2396267066 hasConceptScore W2396267066C2781413609 @default.
- W2396267066 hasConceptScore W2396267066C2911091166 @default.
- W2396267066 hasConceptScore W2396267066C71924100 @default.
- W2396267066 hasConceptScore W2396267066C88879693 @default.
- W2396267066 hasConceptScore W2396267066C90924648 @default.
- W2396267066 hasIssue "2" @default.
- W2396267066 hasLocation W23962670661 @default.
- W2396267066 hasLocation W23962670662 @default.
- W2396267066 hasOpenAccess W2396267066 @default.
- W2396267066 hasPrimaryLocation W23962670661 @default.
- W2396267066 hasRelatedWork W146568283 @default.
- W2396267066 hasRelatedWork W2014926669 @default.
- W2396267066 hasRelatedWork W2030452018 @default.
- W2396267066 hasRelatedWork W2032108990 @default.
- W2396267066 hasRelatedWork W2037648099 @default.
- W2396267066 hasRelatedWork W204526616 @default.
- W2396267066 hasRelatedWork W2126302362 @default.
- W2396267066 hasRelatedWork W2142338120 @default.
- W2396267066 hasRelatedWork W2155940077 @default.
- W2396267066 hasRelatedWork W2351048342 @default.
- W2396267066 hasRelatedWork W2357296641 @default.
- W2396267066 hasRelatedWork W2366401739 @default.
- W2396267066 hasRelatedWork W2376865626 @default.
- W2396267066 hasRelatedWork W2406986246 @default.
- W2396267066 hasRelatedWork W2413755139 @default.
- W2396267066 hasRelatedWork W2415266336 @default.
- W2396267066 hasRelatedWork W2436702184 @default.
- W2396267066 hasRelatedWork W2462506669 @default.
- W2396267066 hasRelatedWork W2464358061 @default.
- W2396267066 hasRelatedWork W3036473897 @default.
- W2396267066 hasVolume "31" @default.
- W2396267066 isParatext "false" @default.
- W2396267066 isRetracted "false" @default.
- W2396267066 magId "2396267066" @default.
- W2396267066 workType "article" @default.